News

"The polyps had eroded so much the bone around the perimeter of the sinuses that they were entering into the brain cavity and ...
Researchers at Columbus-based Ohio State University have designed and developed the world’s first noninvasive devices aimed ...
Bucks County specialty pharmaceutical company Optinose first started exploring mergers and licensing deals in early 2022.
Tezepelumab was linked to significantly reduced nasal polyp size and nasal congestion vs placebo in adults with severe CRSwNP.
In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...